-

08:01:23 PM

LIVE Real Time BHC Stock Market News

BHC - Bausch Health Companies Inc

04/21/21 6:59 AM

NYSE : BHC

Ortho Dermatologics to Present New Data at the 2021 American Academy of Dermatology Annual Meeting

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health

RHEA-AI

neutral

04/16/21 7:00 AM

NYSE : BHC

Bausch Health Announces VYZULTA(R) (latanoprostene bunod ophthalmic solution), 0.024%, is Now Approved In Brazil

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), Bausch + Lomb, its leading global eye health business, and Nicox (Euronext Paris: FR0013018124, COX), an international ophthalmology company,

RHEA-AI

neutral

04/15/21 8:48 AM

NYSE : BHC

New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic

Bausch Health Companies Inc. (NYSE/TSX: BHC)

RHEA-AI

negative

04/15/21 7:00 AM

NYSE : BHC

New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic

Bausch Health Companies Inc. (NYSE/TSX: BHC)

RHEA-AI

negative

04/13/21 6:58 AM

NYSE : VRX, BHC

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), and Novaliq GmbH, a biopharmaceutical company

RHEA-AI

neutral

04/09/21 7:00 AM

NYSE : BHC

Bausch Health Companies Inc. Will Release First-Quarter 2021 Financial Results On May 4

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its first-quarter 2021 financial results on Tuesday, May 4, 2021. Bausch Health will host a conference call and live web cast at 8:00 a.m. EDT to discuss the results and provide a

RHEA-AI

neutral

04/08/21 7:00 AM

NYSE : BHC

Bausch Health Launches ENVIVE(TM) Daily Probiotic Supplement

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced the U.S.

RHEA-AI

neutral

04/07/21 7:30 AM

NYSE : BHC

FDA Approves Bausch + Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that the U.S. Food and Drug

RHEA-AI

neutral

04/07/21 7:00 AM

NYSE : BHC

Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by $100 million through the redemption of outstanding senior secured notes, using cash generated from operations.Bausch Health will

RHEA-AI

neutral

03/31/21 8:00 AM

NYSE : BHC

Bausch Health Agrees To Sell Amoun Pharmaceuticals

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that it and certain of its affiliates have entered into a definitive agreement to sell all of their equity interests in Amoun Pharmaceutical Company S.A.E.

RHEA-AI

very positive

1 2 3 4 5 6 7 8 Next